Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial

OBJECTIVE: Epilepsy is a chronic neurological disorder that affects 0.5%–1% of children. 30%–40% of patients are resistant to current anti-epileptic drugs. Lacosamide (LCM) appeared to be effective, safe, and well tolerated in children and adolescents. This study was aimed to evaluate whether LCM co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, Tayebeh, Nasiri, Jafar, Ghazavi, Mohammad Reza, Yaghini, Omid, Hoseini, Neda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252575/
https://www.ncbi.nlm.nih.gov/pubmed/37304225
http://dx.doi.org/10.4103/jrpp.jrpp_86_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252575/
https://www.ncbi.nlm.nih.gov/pubmed/37304225
http://dx.doi.org/10.4103/jrpp.jrpp_86_21

Ejemplares similares